Back to top
more

Labcorp (LH)

(Delayed Data from NYSE)

$216.00 USD

216.00
308,627

+0.93 (0.43%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $216.01 +0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 33% (168 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

QIAGEN (QGEN) Reports Encouraging Preliminary Q2 Results

by Zacks Equity Research

Preliminary net revenues for second-quarter 2020 improved 18-19% at CER.

Baxter Gets FDA Nod for Altapore Shape Bioactive Bone Graft

by Zacks Equity Research

Baxter (BAX) receives FDA approval for Altapore Shape that will provide surgeons versatile options to advance the art of healing and boost clinical outcomes during a surgery.

Hologic Expands Product Portfolio With New Ultrasound System

by Zacks Equity Research

Hologic's (HOLX) latest cart-based ultrasound system enhances efficiency and accuracy to better meet the requirements of breast imagers and optimize patient care.

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

by Zacks Equity Research

Investor confidence is high on Nevro (NVRO), thanks to solid prospects

Medtronic's LINQ II ICM Gets Multiple Regulatory Approvals

by Zacks Equity Research

Medtronic's (MDT) FDA and CE Mark-approved LINQ II ICM enables physicians to optimize device settings via remote programming, without requiring patients' in-office visits.

Trina Mukherjee headshot

3 GARP MedTech Stocks to Beat Pandemic-Led Market Volatility

by Trina Mukherjee

Here we look at three stocks that investors can add to their watchlist backed by robust long-term prospects.

Medtronic Launches User-Friendly Insulin Infusion Set in US

by Zacks Equity Research

Medtronic's (MDT) MiniMed Mio Advance infusion set, is aimed at providing optimal user experience to insulin pump-using diabetic patients.

LabCorp Launches At-Home Coronavirus Test Collection Kit

by Zacks Equity Research

LabCorp (LH) claims this to be the first digital COVID-19 service that physicians can use to remotely diagnose patients before any surgery or procedure.

BD Receives EUA for New Antigen Test to Combat COVID-19

by Zacks Equity Research

Becton, Dickinson (BDX) receives EUA from the FDA for a rapid, point-of-care, antigen test to detect SARS-CoV-2 in 15 minutes.

BD Unveils BD PurPrep Patient Preoperative Skin Preparation

by Zacks Equity Research

By developing fully sterile PurPrep, BD (BDX) is offering health care experts a more complete set of tools to mitigate the risk of intrinsic contamination in antiseptic solutions.

Here's Why You Should Retain Avanos Medical Stock for Now

by Zacks Equity Research

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

Myriad Genetics, OptraHEALTH Partner to Offer Cancer Knowledge

by Zacks Equity Research

Myriad Genetics (MYGN) collaborates with OptraHEALTH to provide an AI-powered cognitive ChatBOT to serve as a genetic health knowledge platform to prospective hereditary cancer patients.

LH or ALGN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

LH vs. ALGN: Which Stock Is the Better Value Option?

Align Technology's Rollouts Aid Amid Procedural Deferrals

by Zacks Equity Research

Align Technology's (ALGN) new virtual solutions ensure continuity of care amid pandemic.

Thermo Fisher Stock Rises on Solid Q2 Growth Expectation

by Zacks Equity Research

Thermo Fisher (TMO) provides encouraging Q2 guidance for organic growth.

Myriad Genetics Rides on EndoPredict Amid Coronavirus Crisis

by Zacks Equity Research

Myriad Genetics (MYGN) expects to register an uptick in hereditary cancer volumes on account of its contract with UnitedHealthcare.

Pharmaceutical Wholesale to Aid Walgreens' (WBA) Q3 Earnings?

by Zacks Equity Research

Walgreen Boots' (WBA) international businesses in the third quarter is likely to have suffered a huge blow with international trade coming almost to a standstill.

Here's Why You Should Invest in OPKO Health (OPK) Stock Now

by Zacks Equity Research

OPKO Health (OPK) continues to benefit from lucrative prospects in RAYALDEE and BioReference platforms.

    Luminex Boosts Product Portfolio With New xMAP Technology

    by Zacks Equity Research

    Luminex (LMNX) commences rollout of new xMAP INTELLIFLEX Systems, which will expand its xMAP Technology.

      Sriparna Ghosal headshot

      3 Cheap MedTech Stocks Set to Gain Once Coronavirus Crisis Ebbs

      by Sriparna Ghosal

      Once the pandemic-led crisis eases, these MedTech stocks will likely flourish on the back of number of positive developments.

      IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests

      by Zacks Equity Research

      IDEXX's (IDXX) human health business, OPTI Medical Systems' newly-developed PCR laboratory test kit named OPTI SARS-CoV-2 RNA RT-PCR gains market acceptance.

      Boston Scientific's (BSX) ICM System Receives FDA Approval

      by Zacks Equity Research

      Boston Scientific's (BSX) new ICM System gets the FDA's nod, thus paving way for better detection and treatment of arrhythmias.

      Here's Why You Should Retain DaVita in Your Portfolio Now

      by Zacks Equity Research

      Investor confidence is high on DaVita (DVA), thanks to solid prospects.

      Myriad Genetics Unveils New Home DNA Sample Collection Kit

      by Zacks Equity Research

      Myriad Genetics' (MYGN) home DNA sample collection test kit for its GeneSight Psychotropic test enables physicians to remotely provide treatment options to patients with mental health issues.

      Debanjana Dey headshot

      4 Cheap MedTech Stocks Poised to Beat Industry Post-Pandemic

      by Debanjana Dey

      Here are some MedTech stocks which might be a solid investment option post the coronavirus blues.